1998
DOI: 10.1016/s0006-2952(97)00481-4
|View full text |Cite
|
Sign up to set email alerts
|

Induction of leukotriene production by bleomycin and asparaginase in mast cells in vitro and in patients in vivo

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
8
0

Year Published

2000
2000
2019
2019

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 15 publications
(10 citation statements)
references
References 18 publications
0
8
0
Order By: Relevance
“…These conditions result from direct release of inflammatory mediators, such as leukotrienes and prostaglandins [9]. Leukotriene release from mast cell degranulation has been previously observed in patients treated with other chemotherapeutic agents, such as bleomycin and asparaginase [10]. In our case, eosinophil counts remained within normal ranges, and specific IgE levels or other markers of an acute allergic reaction were not measured.…”
Section: Discussionmentioning
confidence: 47%
“…These conditions result from direct release of inflammatory mediators, such as leukotrienes and prostaglandins [9]. Leukotriene release from mast cell degranulation has been previously observed in patients treated with other chemotherapeutic agents, such as bleomycin and asparaginase [10]. In our case, eosinophil counts remained within normal ranges, and specific IgE levels or other markers of an acute allergic reaction were not measured.…”
Section: Discussionmentioning
confidence: 47%
“…E. coli type II l-asparaginase (EcA-II) was found to be localized in the periplasm and to have higher af®nity for l-asparagine than the type I isozyme (EcA-I) (Cedar & Schwartz, 1967). The EcA-II exhibits antitumour activity (Mashburn & Wriston, 1964;Schwartz et al, 1966) and has been used as a drug in the treatment of acute childhood lymphoblastic leukaemia, although the treatment is restricted owing to its multiple in¯ammatory or allergic side effects (Geuenich et al, 1998). The mechanism of the antitumour activity of EcA-II has not yet been completely elucidated.…”
Section: Introductionmentioning
confidence: 99%
“…However, these L-asparaginases can also have undesirable side effects, including anaphylaxis, pancreatitis, diabetes, leucopoenia, neurological seizures, and coagulation abnormalities that may lead to intracranial thrombosis or hemorrhage (7,10). These side effects are considered to arise from allergic responses, and the use of L-asparaginases from different organisms might alleviate the problem (11).…”
mentioning
confidence: 99%